SANDOZ VENLAFAXINE XR venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz venlafaxine xr venlafaxine (as hydrochloride) 150 mg modified release capsule blister pack

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 169.8 mg (equivalent: venlafaxine, qty 150 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; sunset yellow fcf; povidone; magnesium stearate; microcrystalline cellulose; brilliant blue fcf; copovidone; allura red ac; purified talc; colloidal anhydrous silica; titanium dioxide; propylene glycol; ethanol; isopropyl alcohol; shellac; tert-butyl alcohol; sodium hydroxide - sandoz venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

SANDOZ VENLAFAXINE XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz venlafaxine xr venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 84.9 mg (equivalent: venlafaxine, qty 75 mg) - capsule, modified release - excipient ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - sandoz venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

CANDELEM candesartan cilexetil 16 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candelem candesartan cilexetil 16 mg tablet blister pack

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: macrogol 8000; lactose monohydrate; maize starch; magnesium stearate; carmellose calcium; hyprolose; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

CANDELEM candesartan cilexetil 4 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candelem candesartan cilexetil 4 mg tablet blister pack

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: hyprolose; carmellose calcium; maize starch; macrogol 8000; lactose monohydrate; magnesium stearate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

CANDELEM candesartan cilexetil 32 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candelem candesartan cilexetil 32 mg tablet blister pack

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: macrogol 8000; lactose monohydrate; hyprolose; magnesium stearate; carmellose calcium; maize starch; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

CANDELEM candesartan cilexetil 8 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candelem candesartan cilexetil 8 mg tablet blister pack

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: hyprolose; lactose monohydrate; maize starch; macrogol 8000; magnesium stearate; carmellose calcium; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

TERIFLUNOMIDE ALEMBIC teriflunomide 14 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

teriflunomide alembic teriflunomide 14 mg film-coated tablet blister pack

alembic pharmaceuticals australia pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; purified water; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; macrogol 8000; purified talc; indigo carmine aluminium lake - teriflunomide alembic is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability

VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 225 mg modified release capsule Australia - English - Department of Health (Therapeutic Goods Administration)

venlafaxine alembic xr venlafaxine (as hydrochloride) 225 mg modified release capsule

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 254.7 mg (equivalent: venlafaxine, qty 225 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; ethylcellulose; copovidone; carmoisine; titanium dioxide; gelatin; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution - venlafaxine extended release capsule is indicated for the treatment of: major depression, including prevention of relapse and recurrence where appropriate; generalised anxiety disorder; social anxiety disorder; panic disorder, including prevention of relapse.

DESVENLAFAXINE ALEMBIC desvenlafaxine 50 mg extended release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

desvenlafaxine alembic desvenlafaxine 50 mg extended release tablet blister pack

alembic pharmaceuticals australia pty ltd - desvenlafaxine, quantity: 50 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; magnesium stearate; citric acid monohydrate; purified talc; povidone; alginic acid; hypromellose; titanium dioxide; macrogol 6000; iron oxide red - desvenlafaxine alembic is indicated for the treatment of major depressive disorder, including the prevention of relapse.,desvenlafaxine alembic is not indicated for paediatric use.

DESVENLAFAXINE ALEMBIC desvenlafaxine 100 mg extended release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

desvenlafaxine alembic desvenlafaxine 100 mg extended release tablet blister pack

alembic pharmaceuticals australia pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; alginic acid; purified talc; povidone; hypromellose; magnesium stearate; citric acid monohydrate; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - desvenlafaxine alembic is indicated for the treatment of major depressive disorder, including the prevention of relapse.,desvenlafaxine alembic is not indicated for paediatric use.